Your browser doesn't support javascript.
loading
Tackling barriers to COVID-19 vaccine uptake in London: a mixed-methods evaluation.
Halvorsrud, Kristoffer; Shand, Jenny; Weil, Leonora G; Hutchings, Andrew; Zuriaga, Ana; Satterthwaite, Dane; Yip, Jennifer L Y; Eshareturi, Cyril; Billett, Julie; Hepworth, Ann; Dodhia, Rakesh; Schwartz, Ellen C; Penniston, Rachel; Mordaunt, Emma; Bulmer, Sophie; Barratt, Helen; Illingworth, John; Inskip, Joanna; Bury, Fran; Jenkins, Deborah; Mounier-Jack, Sandra; Raine, Rosalind.
Afiliación
  • Halvorsrud K; Department of Applied Health Research, University College London (UCL), London WC1E 7HB, UK.
  • Shand J; UCLPartners, London W1T 7HA, UK.
  • Weil LG; Department of Clinical, Education & Health Psychology, UCL, London WC1E 6BT, UK.
  • Hutchings A; UK Health Security Agency, London SE1 8UG, UK.
  • Zuriaga A; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
  • Satterthwaite D; UK Health Security Agency, London SE1 8UG, UK.
  • Yip JLY; NHS England and NHS Improvement London, London SE1 6LH, UK.
  • Eshareturi C; Office for Health Improvement and Disparities, London region, London SW1H 0EU, UK.
  • Billett J; Public Health England London, London SE1 8UG, UK.
  • Hepworth A; Office for Health Improvement and Disparities, London region, London SW1H 0EU, UK.
  • Dodhia R; NHS England and NHS Improvement London, London SE1 6LH, UK.
  • Schwartz EC; NHS England London Shared Service, London SE1 6LH, UK.
  • Penniston R; Association of Directors of Public Health, London EC4Y 0HA, UK.
  • Mordaunt E; UCLPartners, London W1T 7HA, UK.
  • Bulmer S; UCLPartners, London W1T 7HA, UK.
  • Barratt H; UCLPartners, London W1T 7HA, UK.
  • Illingworth J; Department of Applied Health Research, University College London (UCL), London WC1E 7HB, UK.
  • Inskip J; UCLPartners, London W1T 7HA, UK.
  • Bury F; Office for Health Improvement and Disparities, London region, London SW1H 0EU, UK.
  • Jenkins D; NHS England and NHS Improvement London, London SE1 6LH, UK.
  • Mounier-Jack S; Royal Free London NHS Foundation Trust, London NW3 2QG, UK.
  • Raine R; Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
J Public Health (Oxf) ; 45(2): 393-401, 2023 Jun 14.
Article en En | MEDLINE | ID: mdl-35373295
ABSTRACT

BACKGROUND:

In response to the COVID-19 pandemic, the first vaccine was administered in December 2020 in England. However, vaccination uptake has historically been lower in London than in other English regions.

METHODS:

Mixed-

methods:

This comprised an analysis of cumulative percentage uptake across London between 8 December 2020 and 6 June 2021 by vaccine priority cohorts and ethnicity. We also undertook thematic analyses of uptake barriers, interventions to tackle these and key learning from a qualitative survey of 27 London local authority representatives, vaccine plans from London's five Integrated Care Systems and interviews with 38 London system representatives.

RESULTS:

Vaccine uptake was lower in Black ethnic (57-65% uptake) compared with the White British group (90% uptake). Trust was a critical issue, including mistrust in the vaccine itself and in authorities administering or promoting it. The balance between putative costs and benefits of vaccination created uptake barriers for zero-hour and shift workers. Intensive, targeted and 'hyper-local' initiatives, which sustained community relationships and were not constrained by administrative boundaries, helped tackle these barriers.

CONCLUSIONS:

The success of the national vaccination programme depended on conceding local autonomy, investing in responsive and long-term partnerships to engender trust through in-depth understanding of communities' beliefs.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Vacunas / COVID-19 Tipo de estudio: Qualitative_research Límite: Humans País/Región como asunto: Europa Idioma: En Revista: J Public Health (Oxf) Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Vacunas / COVID-19 Tipo de estudio: Qualitative_research Límite: Humans País/Región como asunto: Europa Idioma: En Revista: J Public Health (Oxf) Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
...